Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:25 AM
Ignite Modification Date:
2025-12-25 @ 4:25 AM
NCT ID:
NCT06839820
Eligibility Criteria:
Inclusion Criteria:
* Pediatric IBD patients on infliximab
* 1-17 years
* Received at least 5 infusions of infliximab prior to entry in the study
Exclusion Criteria:
* Receiving infliximab for non-IBD condition (reumatological or other causes)
* previous severe infliximab infusion reaction
* need for an interpreter
* heart failure with hemodynamic impact
* unwillingness to participate
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Year
Maximum Age:
18 Years
Study:
NCT06839820
Study Brief:
Protocol Section:
NCT06839820